Health knowledge and news provided by doctors.

Ads by Google

Drug Clinical Trials

SPIRIT Clinical Reaffirm Strength of TAXUS, PROMUS Drug-Eluting Coronary Stent Systems

Boston Scientific Corporation welcomed the results of data from the SPIRIT FIRST, II and III Clinical Trials, reaffirming prior safety and efficacy data for TAXUS Express2 Paclitaxel-Eluting Coronary Stent System and XIENCE V Everolimus Eluting Coronary Stent System.

Health and Wellness: 

Manhattan Pharmaceuticals Completes Dosing Portion Of Two Phase 2a Clinical Trials Of Oral Oleoyl-Estrone For Obesity

Manhattan Pharmaceuticals announced it has successfully completed patient dosing in two separate, ongoing Phase 2a clinical trials of oral Oleoyl-estrone.

Health and Wellness: 

Study Of Investigational Drug To Treat Cocaine And Methamphetamine Addiction

Catalyst Pharmaceutical Partners announced positive initial, top-line results from a bioequivalence study demonstrating that CPP-109 (Catalyst's Vigabatrin Tablets) is bioavailable and bioequivalent to Sabril Tablets, the version of vigabatrin marketed in Europe by Sanofi Aventis.

Health and Wellness: 

FDA Approves Continued Access Protocol For HeartMate II Pivotal Trial

Thoratec Corporation said that the FDA has approved an Investigational Device Exemption supplement that allows enrollment of up to an additional 60 patients in the Bridge-to-Transplantation arm of the company's HeartMate II Phase II trial under a Continued Access Protocol.

Health and Wellness: 

Marinus Initiates Phase IIb Study Of Ganaxolone For Adult Partial Seizures

Marinus Pharmaceuticals announced that it is enrolling patients in an international, multi-center, placebo controlled Phase IIb study of its lead compound, Ganaxolone, as an adjunctive treatment in adults suffering from partial onset seizures.

Health and Wellness: 

Medidur Trial Exceeds 500 Patient Mark In Phase 3 Trial Enrollment

Alimera Sciences, a privately held ophthalmic pharmaceutical company, and global drug delivery company pSivida Limited announced that enrollment for their Phase 3 global clinical trial, the FAME (Fluocinolone Acetonide in Diabetic Macular Edema) Study has exceeded 50 percent.

Health and Wellness: 

Drug Telaprevir in Patients with Genotype 1 Hepatitis C May Cut Treatment Time

Interim Results Presented at EASL from PROVE 1 Clinical Trial of Investigational Drug Telaprevir in patients with Genotype 1 Hepatitis C. PROVE 1 data support potential to shorten treatment duration in treatment-naive, genotype 1 HCV patients.

Health and Wellness: 

Rush University Medical Center To Conduct Phase III Clinical Trial Of Creatine For Parkinson's Disease

Rush University Medical Center will participate in a large-scale national clinical trial to learn if the nutritional supplement creatine can slow the progression of Parkinson's disease (PD).

Health and Wellness: 

Intarcia Therapeutics Announces Results From Phase 2 Study Of Injectable Omega Interferon Plus Ribavirin

Intarcia Therapeutics Inc. announced final results from a Phase 2 study of omega interferon with or without ribavirin in treatment-naive patients with genotype 1 chronic hepatitis C.

Health and Wellness: 

Oncolytics Biotech Proceeds To Initiate U.S. Phase II Sarcoma Clinical Trial

Oncolytics Biotech Inc. announced that subsequent to the regulatory review period for this submission, it is proceeding with a Phase II trial to evaluate the intravenous administration of REOLYSIN in patients with various sarcomas that have metastasized to the lung.

Health and Wellness: